Literature DB >> 19118601

Immunolocalization of alpha-synuclein in the rat spinal cord by two novel monoclonal antibodies.

G Vivacqua1, J-J Yin, A Casini, X Li, Y-H Li, L D'Este, P Chan, T G Renda, S Yu.   

Abstract

This study provides the first immunohistochemical evidence of the presence and distribution patterns in the rat spinal cord of alpha-synuclein (alpha-Syn), a soluble acidic protein, widely expressed in the CNS and closely associated to the pathogenesis of neurodegenerative conditions such as Parkinson's and Alzheimer's diseases. We used two novel homemade monoclonal antibodies (2E3 and 3D5) recognizing two different epitopes of alpha-Syn. Both antibodies localized alpha-Syn within the nerve terminals, whereas 3D5 alone also localized it within the neuronal nuclei. alpha-Syn-immunoreactive nervous elements were widely recognized throughout rat spinal cord and in almost all the gray matter laminae. However, they appeared particularly concentrated within laminae I, II, VII and X and more scattered in the others. Double immunofluorescent labeling showed that alpha-Syn colocalized with synaptophysin in the presynaptic nerve terminals, with neuropeptide Y (NPY) in lamina I, II, IX and X, and had close relationships with tyrosine hydroxylase (TH) immunoreactive neurons in laminae VII and X. Interestingly, the alpha-Syn-immunoreactive nerve elements, in lamina X, contained little of calbindin-28KD and calretinin-31KD. Our findings could help in understanding the genesis of some early clinical symptoms of Parkinson's disease (PD), such as pain and dysautonomic disorders, and indicate the spinal cord as their probable starting point, according to the ascending theory of PD, proposed by Braak.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19118601     DOI: 10.1016/j.neuroscience.2008.12.001

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  10 in total

1.  Plasma alpha-synuclein levels in patients with Parkinson's disease: a systematic review and meta-analysis.

Authors:  Anastasia Bougea; Leonidas Stefanis; George P Paraskevas; Evangelia Emmanouilidou; Kostas Vekrelis; Elisabeth Kapaki
Journal:  Neurol Sci       Date:  2019-02-04       Impact factor: 3.307

2.  Spinal cord involvement in Lewy body-related α-synucleinopathies.

Authors:  Raffaele Nardone; Yvonne Höller; Francesco Brigo; Viviana Versace; Luca Sebastianelli; Cristina Florea; Kerstin Schwenker; Stefan Golaszewski; Leopold Saltuari; Eugen Trinka
Journal:  J Spinal Cord Med       Date:  2019-01-08       Impact factor: 1.985

Review 3.  Tracking extranigral degeneration in animal models of Parkinson's disease: quest for effective therapeutic strategies.

Authors:  Varduhi H Knaryan; Supriti Samantaray; Charlene Le Gal; Swapan K Ray; Naren L Banik
Journal:  J Neurochem       Date:  2011-06-17       Impact factor: 5.372

4.  Determining nuclear localization of alpha-synuclein in mouse brains.

Authors:  Z Huang; Z Xu; Y Wu; Y Zhou
Journal:  Neuroscience       Date:  2011-10-19       Impact factor: 3.590

5.  Motor Neurons Pathology After Chronic Exposure to MPTP in Mice.

Authors:  Giorgio Vivacqua; Francesca Biagioni; Carla L Busceti; Michela Ferrucci; Michele Madonna; Larisa Ryskalin; Shun Yu; Loredana D'Este; Francesco Fornai
Journal:  Neurotox Res       Date:  2019-11-13       Impact factor: 3.911

6.  Icariin reduces α-synuclein over-expression by promoting α-synuclein degradation.

Authors:  Lan Zhang; Cong Shen; Jin Chu; Ying Liu; Yali Li; Li Zhang; Lin Li
Journal:  Age (Dordr)       Date:  2015-07-14

7.  The Role of AlphαSynuclein in Mouse Models of Acute, Inflammatory and Neuropathic Pain.

Authors:  Moritz Möller; Christine V Möser; Ulrike Weiß; Ellen Niederberger
Journal:  Cells       Date:  2022-06-19       Impact factor: 7.666

8.  The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of α-synuclein, and enhances its secretion and nuclear localization in cells.

Authors:  Mohamed-Bilal Fares; Nadine Ait-Bouziad; Igor Dikiy; Martial K Mbefo; Ana Jovičić; Aoife Kiely; Janice L Holton; Seung-Jae Lee; Aaron D Gitler; David Eliezer; Hilal A Lashuel
Journal:  Hum Mol Genet       Date:  2014-04-11       Impact factor: 6.150

9.  Comparison of alpha-synuclein immunoreactivity in the spinal cord between the adult and aged beagle dog.

Authors:  Ji-Hyeon Ahn; Jung-Hoon Choi; Joon-Ha Park; Bing-Chun Yan; In-Hye Kim; Jae-Chul Lee; Dae-Hwan Lee; Jin-Sang Kim; Hyung-Cheul Shin; Moo-Ho Won
Journal:  Lab Anim Res       Date:  2012-09-26

Review 10.  A Focus on the Beneficial Effects of Alpha Synuclein and a Re-Appraisal of Synucleinopathies.

Authors:  Larisa Ryskalin; Carla L Busceti; Fiona Limanaqi; Francesca Biagioni; Stefano Gambardella; Francesco Fornai
Journal:  Curr Protein Pept Sci       Date:  2018       Impact factor: 3.272

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.